PRECLINICAL DEVELOPMENT OF SMALL MOLECULE INHIBITORS
TARGETING HUMAN ADIPOSE TRIGLYCERIDE LIPASE
The global burden of obesity and co-morbitidies, such as type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. Successful therapy of these conditions requires effective treatment strategies. The present application focuses on the development of novel anti-diabetic, lipid-lowering,…